Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism

References

• SteinPDMattaFEpidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolismCrit Care Clin201127490793222082520
   PubMed Web of Science ®Google Scholar
• SteinPDMattaFKeyesDCWillyerdGLImpact of vena cava filters on in-hospital case fatality rate from pulmonary embolismAm J Med2012125547848422310013
   PubMed Web of Science ®Google Scholar
• SteinPDMattaFThrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underusedAm J Med2012125546547022325236
   PubMed Web of Science ®Google Scholar
• SteinPDMattaFCase fatality rate with pulmonary embolectomy for acute pulmonary embolismAm J Med2012125547147722482845
   PubMed Web of Science ®Google Scholar
• KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141Suppl 2e419Se494S22315268
   PubMed Web of Science ®Google Scholar
• GoldhaberSZHaireWDFeldsteinMLAlteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionLancet199334188445075118094768
   PubMed Web of Science ®Google Scholar
• RibeiroALindmarkerPJuhlin-DannfeltAJohnssonHJorfeldtLEchocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rateAm Heart J199713434794879327706
   PubMed Web of Science ®Google Scholar
• GrifoniSOlivottoICecchiniPShort-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunctionCirculation2000101242817282210859287
   PubMed Web of Science ®Google Scholar
• KearonCKahnSRAgnelliGGoldhaberSRaskobGEComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest2008133Suppl 6454S545S18574272
   PubMed Web of Science ®Google Scholar
• British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development GroupBritish Thoracic Society guidelines for the management of suspected acute pulmonary embolismThorax200358647048312775856
   PubMed Web of Science ®Google Scholar
• PiazzaGGoldhaberSZManagement of submassive pulmonary embolismCirculation2010122111124112920837937
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCSubcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patientsJ Thromb Haemost20053469269415842354
   PubMed Web of Science ®Google Scholar
• MillerGASuttonGCKerrIHGibsonRVHoneyMComparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolismBr Med J1971257636816845556052
   PubMed Web of Science ®Google Scholar
• BellWRSimonTLStengleJMSherrySThe urokinase-streptokinase pulmonary embolism trial (phase II) resultsCirculation1974506107010714430106
   PubMed Web of Science ®Google Scholar
• SasahraAABellWRSimonTLStengleJMSherrySThe phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative studyThromb Diath Haemorrh19753334644761098216
   PubMedGoogle Scholar
• BellWRStreptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative studyThromb Haemost19763515769785689
   PubMed Web of Science ®Google Scholar
• CharbonnierBMulticenter study of 2 urokinase protocols in severe pulmonary embolism. Research Group on Urokinase and Pulmonary EmbolismArch Mal Coeur Vaiss1984777773781 French [with English abstract]6433840
   PubMedGoogle Scholar
• GiuntiniCMariniCDi RiccoGPallaRGiacomelliVRindiMA controlled clinical trial on the effect of heparin infusion and two regimens of urokinase in acute pulmonary embolismG Ital Cardiol198414Suppl 126296398781
   PubMedGoogle Scholar
• FrançoisGCharbonnierBRaynaudPGarnierLFGriguerPBrochierMTreatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 casesArchives des Maladies du Coeur et des Vaisseaux1986794435442 French [with English abstract]3090961
   PubMedGoogle Scholar
• GoldhaberSZKesslerCMHeitJRandomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolismLancet1988286062932982899718
   PubMed Web of Science ®Google Scholar
• SasaharaAAHenkinJJanickiRSUrokinase versus tissue plasminogen activator in pulmonary embolismLancet1988286126916922901554
   PubMedGoogle Scholar
• VerstraeteMMillerGABounameauxHIntravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolismCirculation19887723533603123091
   PubMed Web of Science ®Google Scholar
• GoldhaberSZTPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trialVasa Suppl1989272922942516368
   PubMedGoogle Scholar
• GoldhaberSZKesslerCMHeitJARecombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJ Am Coll Cardiol199220124301607532
   PubMed Web of Science ®Google Scholar
• MeyerGSorsHCharbonnierBEffects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary EmbolismJ Am Coll Cardiol19921922392451732347
   PubMed Web of Science ®Google Scholar
• SorsHPacouretGAzarianRMeyerGCharbonnierBSimonneauGHemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trialChest199410637127178082346
   PubMed Web of Science ®Google Scholar
• GoldhaberSZAgnelliGLevineMNReduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism GroupChest199410637187248082347
   PubMed Web of Science ®Google Scholar
• AgnelliGIorioAParisePGoldhaberSZLevineMNFibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism GroupBlood Coagul Fibrinolysis1997842162229199818
   PubMed Web of Science ®Google Scholar
• MeneveauNSchieleFVuillemenotAStreptokinase vs alteplase in massive pulmonary embolism. A randomized trial assessing right heart haemodynamics and pulmonary vascular obstructionEur Heart J1997187114111489243149
   PubMed Web of Science ®Google Scholar
• MeneveauNSchieleFMetzDComparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-upJ Am Coll Cardiol1998315105710639562007
   PubMed Web of Science ®Google Scholar
• TebbeUGrafAKamkeWHemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolismAm Heart J19991381394410385761
   PubMed Web of Science ®Google Scholar
• WangCZhaiZYangYChina Venous Thromboembolism Study GroupEfficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trialRespir Res200910112820040086
   PubMed Web of Science ®Google Scholar
• WangCZhaiZYangYChina Venous Thromboembolism (VTE) Study GroupEfficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trialChest2010137225426219741062
   PubMed Web of Science ®Google Scholar
• WuYQTaoLBLüCHuYHAn economic evaluation of low dose recombinant human tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolismZhonghua Yi Xue Za Zhi2010902103106 Chinese [with English abstract]20356492
   PubMedGoogle Scholar
• AbdelsamadAAEl-MorsiASMansourAEEfficacy and safety of high dose versus low dose streptokinase for treatment of submassive pulmonary embolismThe Egyptian Heart Journal20116326772
   Google Scholar
• YangYWangYMaZEfficacy and safety of two-hour regimen of recombinant streptokinase versus urokinase in massive and submassive pulmonary embolism: A randomized controlled trialRespirology201116309
   Web of Science ®Google Scholar
• ElliotMSImmelmanEJJefferyPA comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trialBr J Surg19796612838843389338
   PubMed Web of Science ®Google Scholar
• DotterCTSeamanAJRöschJPorterJMStreptokinase and heparin in the treatment of pulmonary embolism: a randomized comparisonVascular and Endovascular Surgery19791314252
   Google Scholar
• SharmaGVRKBurlesonVASasaharaAAEffect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolismN Engl J Med1980303158428457412801
   PubMed Web of Science ®Google Scholar
• LevineMHirshJWeitzJA randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolismChest1990986147314792123152
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED InvestigatorsChest19909735285332106408
   PubMed Web of Science ®Google Scholar
• Dalla-VoltaSPallaASantolicandroAPAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2J Am Coll Cardiol19922035205261512328
   PubMed Web of Science ®Google Scholar
• KonstantinidesSGeibelAHeuselGHeinrichFKasperWManagement Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolismN Engl J Med2002347151143115012374874
   PubMed Web of Science ®Google Scholar
• BecattiniCAgnelliGSalviATIPES Study GroupBolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolismThromb Res20101253e82e8619833379
   PubMed Web of Science ®Google Scholar
• FasulloSScalzoSMaringhiniGSix-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparinAm J Med Sci20113411333920890176
   PubMed Web of Science ®Google Scholar
• ThabutGThabutDMyersRPThrombolytic therapy of pulmonary embolism: a meta-analysisJ Am Coll Cardiol20024091660166712427420
   PubMed Web of Science ®Google Scholar
• WanSQuinlanDJAgnelliGEikelboomJWThrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trialsCirculation2004110674474915262836
   PubMed Web of Science ®Google Scholar
• KonstantinidesSClinical practice. Acute pulmonary embolismN Engl J Med2008359262804281319109575
   PubMed Web of Science ®Google Scholar
• GoldhaberSZVisaniLDe RosaMAcute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)Lancet199935391621386138910227218
   PubMed Web of Science ®Google Scholar
• UcarEYArazOAkgunMLow-molecular-weight heparin use with thrombolysis: is it effective and safe? Ten years’ clinical experienceRespiration201386431832323406693
   PubMed Web of Science ®Google Scholar
• Riera-MestreAJiménezDMurielARIETE investigatorsThrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolismJ Thromb Haemost201210575175922417297
   PubMed Web of Science ®Google Scholar
• HamelEPacouretGVincentelliDThrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilatation: results from a 128-patient monocenter registryChest2001120112012511451826
   PubMed Web of Science ®Google Scholar
• KonstantinidesSMarderVJThrombolysis in venous thromboembolic diseaseColmanRWMarderVJClowesAWGeorgeJNGoldhaberSZHemostasis and Thrombosis: Basic Principles and Clinical Practice5th edPhiladelphia, PALippincott Williams & Wilkins200613171329
   Google Scholar
• Assistance Publique, Hôpitaux de ParisPEITHO pulmonary embolism thrombolysis study Available from http://clinicaltrials.gov/ct2/show/NCT00639743?term=PEITHO+pulmonary+embogov/ct2/show/NCT00639743?term=PEITHO+pulmonary+embolism+thrombolysis+study&rank=1. NLM identifer: NCT00639743Accessed December 21, 2011
   Google Scholar